Lonza Group stock slips after a fresh U.S. factory start
Published on 09/15/2026 at 14:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Lonza Group stock (ISIN CH0013841017) closed at CHF 531.20 on September 11, 2026, down 0.7 percent from the prior session, while the 52-week range ran from CHF 454.60 to CHF 597.80 on August 25, 2026.
Bend adds a new catalyst
Lonza said on September 14, 2026 that it began construction of a new pharmaceutical manufacturing facility in Bend, Oregon, and expects more than 80 new jobs from the project, according to Lonza. The company also said the site is meant to strengthen Central Oregon's role in medicines development and manufacturing.
For investors, the number matters because the project adds a concrete industrial milestone on top of a stock that had already been trading within a wide annual band in recent sessions.
Price stays in range
On September 15, 2026, Valiant showed Lonza at CHF 530.20 at 11:28, with an opening price of CHF 531.40, a prior close of CHF 534.20 and a daily change of -0.75 percent. The same market data page also listed the 52-week low at CHF 454.60 on March 23, 2026 and the 52-week high at CHF 597.80 on August 25, 2026.
Finanzen.ch put the stock at CHF 530.40 at 12:28 on September 15, 2026, down 0.7 percent, which leaves the share price far above the yearly low and still below the yearly peak.
What the chart says
Lonza's latest quote sits about CHF 67.60 below the 52-week high and about CHF 75.60 above the 52-week low, a gap that keeps the chart in the middle of its yearly corridor. That pattern matters more than a single session move because the stock is still trading close to the CHF 530 area.
Lonza Group at a glance
- Company: Lonza Group AG
- ISIN: CH0013841017
- Ticker: LONN
- Trading venue: SIX Swiss Exchange
- Price (as of September 15, 2026, 11:28): CHF 530.20
- Market capitalization: CHF 39.9 billion
- Sector / Industry: Health Care / Life Sciences Tools & Services
- Index membership: SMI
More Lonza news
